WORCESTER, Mass.--(BUSINESS WIRE)--Generex Biotechnology Corporation (NasdaqCM:GNBT) (www.generex.com), the leader in drug delivery for metabolic diseases through the inner lining of the mouth, today announced that Professor Paolo Pozzilli of the Department of Endocrinology & Diabetes at University Campus Bio-Medico, Rome, Italy, will make a podium presentation in respect of Generex Oral-lyn, the Company’s proprietary oral insulin spray product, at the International Conference on Advances in Diabetes and Insulin Therapy to be held in Mumbai, India, March 19 – 22, 2009 (www.adit2009.org).
